Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Operating Expenses Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Expenses
-$217.2m
CAGR 3-Years
2%
CAGR 5-Years
-25%
CAGR 10-Years
-30%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Operating Expenses
-CA$7.4m
CAGR 3-Years
-148%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Operating Expenses
-$55.9m
CAGR 3-Years
6%
CAGR 5-Years
-7%
CAGR 10-Years
-14%
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Expenses
-$167.4m
CAGR 3-Years
-46%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Operating Expenses
-CA$17.9m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
-18%
Spectral Medical Inc
TSX:EDT
Operating Expenses
-CA$14.4m
CAGR 3-Years
-17%
CAGR 5-Years
-21%
CAGR 10-Years
0%

See Also

What is Aurinia Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-217.2m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Operating Expenses amounts to -217.2m USD.

What is Aurinia Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-30%

Over the last year, the Operating Expenses growth was 9%. The average annual Operating Expenses growth rates for Aurinia Pharmaceuticals Inc have been 2% over the past three years , -25% over the past five years , and -30% over the past ten years .

Back to Top